Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
暂无分享,去创建一个
[1] A. Nademanee,et al. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor , 2017, Hematological oncology.
[2] Sunil V. Rao,et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. , 2016, JAMA.
[3] J. Szer,et al. A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] S. Crawford,et al. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] Benjamin Djulbegovic,et al. Platelet Transfusion: A Clinical Practice Guideline From the AABB , 2015, Annals of Internal Medicine.
[6] O. Hyrien,et al. Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis , 2013, Bone Marrow Transplantation.
[7] B. Johansson,et al. Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery , 2012, Medical Oncology.
[8] A. Gratwohl,et al. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology , 2010, Haematologica.
[9] B. Labar,et al. Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome. , 2010, Collegium antropologicum.
[10] S. Ganguly,et al. Role of transfusion in stem cell transplantation: a freedom-from-transfusion (FFT), cost and survival analysis , 2010, Journal of medical economics.
[11] A. Ozet,et al. Factors affecting engraftment time in autologous peripheral stem cell transplantation. , 2010, Asian Pacific journal of cancer prevention : APJCP.
[12] D. Benvegnú,et al. Successful Hematopoietic Stem Cell Transplantation (hsct), Both Autologous and Allogeneic, Requires a Rapid and Durable Engraftment, with Neutrophil (>500/μl) and Platelet (>20,000/ Μl) Reconstitution. Factors Influencing Engraftment after Autolo- Gous or Allogeneic Hsct Were Investigated in 65 Pati , 2022 .
[13] A. Nademanee,et al. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation , 2007, Transfusion.
[14] J. Armitage,et al. Autologous Hematopoietic Cell Transplantation for Non‐Hodgkin's Lymphoma , 2007 .
[15] S. Alshemmari,et al. Factors influencing engraftment in autologous peripheral stem cell transplantation. The experience of a local Kuwaiti transplantation center. , 2007, Saudi medical journal.
[16] U. Ergene,et al. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT). , 2006, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[17] Mark Ende,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[18] A. Sempere,et al. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies , 2002, Bone Marrow Transplantation.
[19] N. Schmitz,et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.
[20] D. Blaise,et al. Enhanced activation of B cells in a granulocyte colony‐stimulating factor‐mobilized peripheral blood stem cell graft , 2001, British journal of haematology.
[21] L. Villalón,et al. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. , 2000, The hematology journal : the official journal of the European Haematology Association.
[22] M. Offidani,et al. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. , 1998, Haematologica.
[23] D. Huhn,et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] B. Barlogie,et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. , 1995, Blood.
[25] G. Kandel,et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. , 1992, Bone marrow transplantation.